This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Mtm Laboratories, Ag, Roche Mtm Laboratories Ag. Active years: 2011-2014.
Company Filing History:
Years Active: 2011-2014
Title: Innovations in Cancer Detection and Treatment by Johannes Gebert
Introduction
Johannes Gebert is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of cancer research, particularly in the detection and treatment of disorders associated with frameshift mutations. With a total of 2 patents, his work has the potential to impact the lives of many patients suffering from various forms of cancer.
Latest Patents
Gebert's latest patents focus on compounds and methods useful for the detection and treatment of cancer. One of his inventions relates to compounds that are applicable in cancers, especially those associated with DNA mismatch repair deficient (MMR) sporadic tumors and hereditary nonpolyposis colorectal cancer (HNPCC). These compounds are designed for both the detection of disorders and therapeutic applications, including immunotherapy. The diagnostic methods he developed aim to assess disorders linked to frameshift polypeptides originating from frameshift mutations in coding microsatellite regions of genes. His innovative approach utilizes immunological entities directed against these polypeptides found in body fluids. Furthermore, his methods for treating cancer involve immunotherapy with combinatorial mixtures of tumor-specific frameshift peptides, which elicit a cytotoxic T-cell response specifically targeting tumor cells.
Career Highlights
Throughout his career, Johannes Gebert has worked with several prominent companies in the biotechnology and pharmaceutical sectors. Notable among these are Mtm Laboratories and Roche. His experience in these organizations has allowed him to refine his expertise in cancer research and develop groundbreaking inventions.
Collaborations
Gebert has collaborated with esteemed colleagues such as Stefan Woerner and Ruediger Ridder. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Johannes Gebert's innovative work in cancer detection and treatment showcases his dedication to improving patient outcomes through scientific research. His contributions to the field are invaluable and highlight the importance of continued innovation in medical science.